scPharmaceuticals Inc.

Pharmaceutical Preparations·BURLINGTON, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/19/25	→
10-Q/A	Q3 2024	9/30/24	12/31/24	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

33 shown

Filed	Period
8/7/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/19/25	Q1 FY2025	→
1/10/25	Q4 FY2025	→
11/13/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

47 shown

Filed	Type	Description
10/7/25	Delisting	Termination of a Material Definitive Agreement	→
9/24/25	Agreement	Entry into a Material Definitive Agreement	→
8/25/25	Agreement	Entry into a Material Definitive Agreement	→
8/25/25	Agreement	Entry into a Material Definitive Agreement	→
6/9/25	Vote	Submission of Matters to a Vote of Security Holders	→
12/11/24	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

36 shown

Filed	Form	Description
10/7/25	S-8 POS	S-8 POS	→
10/7/25	S-8 POS	S-8 POS	→
10/7/25	S-8 POS	S-8 POS	→
10/7/25	S-8 POS	S-8 POS	→
10/7/25	S-8 POS	S-8 POS	→
10/7/25	S-8 POS	S-8 POS	→
↓

Filing History(421 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 11, 2026

0001357550-26-000003

—

74.1 KB

EFFECT

Nov 19, 2025

9999999995-25-003318

—

1.7 KB

EFFECT

Nov 19, 2025

9999999995-25-003315

—

1.7 KB

EFFECT

Nov 19, 2025

9999999995-25-003314

—

1.7 KB

SCHEDULE 13G/A

Nov 14, 2025

0000935836-25-000685

—

6.1 KB

SCHEDULE 13G

Nov 12, 2025

0001357550-25-000034

—

74.3 KB

SCHEDULE 13G/A

Nov 10, 2025

0001493152-25-021423

—

9.1 KB

15-12G

Oct 17, 2025

0001193125-25-24242515-12G

—

11.6 KB

SCHEDULE 13G

Oct 14, 2025

0000902664-25-004400

—

13.5 KB

SCHEDULE 13G/A

Oct 8, 2025

0001193125-25-234639

—

8.9 KB

Oct 7, 2025

0001193125-25-2335394

Oct 7, 2025

13.9 KB

Oct 7, 2025

0001193125-25-2335374

Oct 7, 2025

12.3 KB

Oct 7, 2025

0001193125-25-2335364

Oct 7, 2025

10.3 KB

Oct 7, 2025

0001193125-25-2335354

Oct 7, 2025

14.3 KB

Oct 7, 2025

0001193125-25-2335344

Oct 7, 2025

12.2 KB

Oct 7, 2025

0001193125-25-2335334

Oct 7, 2025

16.4 KB

Oct 7, 2025

0001193125-25-2335324

Oct 7, 2025

16.6 KB

Oct 7, 2025

0001193125-25-2335314

Oct 7, 2025

8.3 KB

Oct 7, 2025

0001193125-25-2335304

Oct 7, 2025

10.2 KB

Oct 7, 2025

0001193125-25-2335284

Oct 7, 2025

14.4 KB

S-8 POS

Oct 7, 2025

0001193125-25-233508S-8 POS

—

33.8 KB

S-8 POS

Oct 7, 2025

0001193125-25-233505S-8 POS

—

33.8 KB

S-8 POS

Oct 7, 2025

0001193125-25-233503S-8 POS

—

33.8 KB

S-8 POS

Oct 7, 2025

0001193125-25-233502S-8 POS

—

33.8 KB

S-8 POS

Oct 7, 2025

0001193125-25-233497S-8 POS

—

33.8 KB

25 filings shown

Filed	Form	Description
4/21/25	DEFA14A	DEFA14A	→
4/21/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/12/24	PRE 14A	PRE 14A	→
4/27/23	DEFA14A	DEFA14A	→
↓

scPharmaceuticals Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(421 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/11/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/19/25	EFFECT	EFFECT	→
11/19/25	EFFECT	EFFECT	→
11/19/25	EFFECT	EFFECT	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/12/25	SCHEDULE 13G	SCHEDULE 13G	→
↓